XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Retained earnings
Accumulated other comprehensive income (loss), net
Beginning balance, shares at Dec. 31, 2021   35,105,779    
Beginning balance at Dec. 31, 2021 $ 854,432 $ 551,798 $ 293,238 $ 9,396
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock awards forfeited, shares   101,683    
Stock-based compensation expense 950 $ 950    
Common stock repurchased, shares   (105,090)    
Common stock repurchased (2,652) $ (2,652)    
Net income 19,757   19,757  
Other comprehensive income (loss), net of tax (43,624)     (43,624)
Cash dividends declared on common stock (7,414)   (7,414)  
Ending balance, shares at Mar. 31, 2022   35,102,372    
Ending balance at Mar. 31, 2022 821,449 $ 550,096 305,581 (34,228)
Beginning balance, shares at Dec. 31, 2022   35,106,697    
Beginning balance at Dec. 31, 2022 797,893 $ 552,397 345,346 (99,850)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock awards forfeited, shares   116,502    
Stock-based compensation expense 1,099 $ 1,099    
Exercised (in shares)   (115,079)    
Exercise of stock options (2,627) $ (2,627)    
Net income 20,457   20,457  
Other comprehensive income (loss), net of tax 17,053     17,053
Cash dividends declared on common stock (7,793)   (7,793)  
Ending balance, shares at Mar. 31, 2023   35,108,120    
Ending balance at Mar. 31, 2023 $ 826,082 $ 550,869 $ 358,010 $ (82,797)